This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

AMPA Blockade May Be the Mechanism Underlying the Efficacy of Topiramate in PTSD

Daniele F. Zullino, MD; Sonia Krenz, Mapsych; and Jacques Besson, MD

Published: February 15, 2003

Article Abstract

Sir: We read with great interest the report of Berlant and van Kammen on topiramate in posttraumatic stress disorder (PTSD). They report particularly on suppression of nightmares and flashbacks and propose the suppression of kindling mechanisms as underlying topiramate’s efficacy for these symptoms. We would propose a further possible mechanism, which has not been considered by the authors.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 64

Quick Links: PTSD , Trauma

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...